AbbVie Inc's Fiscal Year is From January To December - All Figures are in Billions.
The item "Diluted-Average-Shares" stands at 7.09 Billion for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 03/31/2024.
AbbVie Inc's third quarter result of 1.77 Billion for the item "Diluted Average Shares" represents no change compared to it's second quarter result.
Also, AbbVie Inc's third quarter result of 1.77 Billion for the item "Diluted Average Shares" represents no change compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), AbbVie Inc's third quarter result of 7.09 Billion for the item "Diluted Average Shares" represents no change compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.0141 percent compared to the value the year prior.
The 1 year change in percent is 0.0141.
The 3 year change in percent is -0.2673.
The 5 year change in percent is 10.94.
The 10 year change in percent is 9.03.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Diluted Average Shares | 905,699,262,464.00 |
![]() | Johnson & Johnson - Diluted Average Shares | 486,508,953,600.00 |
![]() | Roche Holding AG - Diluted Average Shares | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Diluted Average Shares | 280,205,508,085.11 |
![]() | Novartis AG - Diluted Average Shares | 255,096,620,580.91 |